NCT06087198View on ClinicalTrials.gov

Clinical Performance Evaluation of T-TAS®01 HD Chip

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Thrombocytopenia
Interventions
DIAGNOSTIC_TEST

T-TAS 01 HD Assay

Disposable flow chamber microchip containing thrombogenic path to facilitate thrombus formation and occlusion

Trial Locations (6)

21215

Sinai Hospital of Baltimore, Baltimore

27710

Duke University, Durham

68198

University of Nebraska Medical Center, Omaha

73104

University of Oklahoma, Oklahoma City

80217

University of Colorado Anschutz Medical Campus, Denver

94112

San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

Fujimori Kogyo Co., Ltd.

UNKNOWN

lead

Hikari Dx, Inc.

OTHER

NCT06087198 - Clinical Performance Evaluation of T-TAS®01 HD Chip | Biotech Hunter | Biotech Hunter